Oxford Biomedica. 2005 to see 'Huge value creation' (Panmure Gordon)

That's the problem, in the UK we just see short term, no bl**dy sense.

OXB has massive potential (yes only potential at the moment) but I will bet
virtually all the big/medium Bio's and Pharma's are watching very closely,
waiting for the first one to move in on them.

Why would you be happy with 100% profit, when if all carries on the way it has
with the science, we could be part owners of a billion pound+ company in a
few years?

The next best option for me, is that they merge with a like sized UK company
with similar good pipeline and grow. Is there one out there?

I like others was wrong footed when the placing was announced, as I had half
expected it with the last results. When it didn't come, I thought it was
because a deal was about to be signed.

Like many I was very cheesed off with AK/EVO, but the deed has been done and we must now see evidence from OXB to confirm our faith.

DYOR